PCM
KNTE

Prelude Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Prelude Capital Management’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,014
Closed -$54.5K – 1457
2023
Q4 		$54.5K Sell
23,014
-9,295
-29% -$22K ﹤0.01% 937
2023
Q3 		$45.2K Buy
32,309
+3,555
+12% +$4.98K ﹤0.01% 909
2023
Q2 		$87.1K Buy
+28,754
New +$87.1K 0.01% 825